Report an error

Spotted something inaccurate in “PCOS Rebranded PMOS: GLP-1 Agonists Emerge as Weight-Loss Option with Periconceptual Caveats”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.